Cyclin A/B RxL inhibitors | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

341,129 results for “Cyclin A/B RxL inhibitors”

Trials

View all 284582 →

Active, not recruiting

Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study

300 participants · First posted Jun 6, 2025

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

231 participants · First posted Nov 15, 2018

Active, not recruiting

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

220 participants · First posted Aug 29, 2024

Drugs

View all 10451 →

CDK2/cyclin A inhibitors (Genentech)

LDC-9-A

Cyclin-dependent kinase inhibitors(Banyu)

Organizations

View all 5371 →

AB&B BIO-TECH-B

B R B Software Systems Inc

United States

VIGONVITA-B

News

View all 40725 →

Circle Pharma to Reveal Dual Mechanism of Novel Cyclin A/B RxL Inhibitors at AACR 2025

Circle Pharma's Novel Cyclin Inhibitor Shows Promise Against E2F-Driven Cancers in Nature Study

Circle Pharma's CID-078 Receives FDA Orphan Drug Designation for Small Cell Lung Cancer Treatment

Page 1 of 34113